iris dorbian
San Francisco-based Averon, a developer of a mobile identity verification standard, has raised $5 million in Series A1 financing. The lead investors were Avalon Ventures and Salesforce founder and CEO Marc Benioff.
Sift Science, a provider of fraud prevention and risk management solutions using real-time machine learning, has secured $53 million in Series D funding. Stripes Group led the round with participation from return backers Union Square Ventures, Insight Venture Partners and Spark Capital.
The Riveter, a female-forward company focused on creating spaces online and in the physical world for entrepreneurs, remote workers and freelancers, has raised $4.75 million in funding. Madrona Venture Group led the round.
San Francisco-based Fauna Inc, a transactional NoSQL database, has raised $25 million in Series A funding. The investors included Capital One Growth Ventures, GV, Point72 Ventures, Afore Capital and Costanoa Ventures.
Sunnyvale, California-based Clari, a provider of AI solutions for sales, has secured $35 million in financing. Tenaya Capital led the round with participation from Thomvest Ventures, Blue Cloud Ventures, Sequoia Capital, Bain Capital Ventures and Northgate Capital.
New York City and Los Angeles-based accelerator Quake Capital has named Priscilla Pesci as a partner. In her new role, Pesci will oversee the LA office and its new LA accelerator program. Pesci's work background includes holding executive positions at such companies as MGM Studios, Lionsgate Entertainment, CBS Broadcast International and FOX Studios.
Denver and Los Angeles-based Vangst, a cannabis jobs marketplace, has raised $2.5 million in funding. Lerer Hippeau led the round with participation from Casa Verde Capital.
California and India-based Chargebee, a SaaS subscription management and recurring billing solution, has secured $18 million in Series C funding. Insight Venture Partners led the round with participation from Accel Partners and Tiger Global Management.
CryptoKitties, a blockchain game, has raised $12 million in funding, according to a blog post. Andreessen Horowitz and Union Square Ventures led the round.
Cambridge, Massachusetts-based TCR2 Therapeutics Inc, an immuno-oncology company, has raised $125 million in Series B funding. The lead investors were 6 Dimensions Capital and Curative Ventures. Other investors in the round included Redmile Group, ArrowMark Partners, Hillhouse Capital Group, MiraeAsset Financial Group, Lucion Group, Sirona Capital, Alexandria Venture Investments, MPM Capital, F2 Ventures and Cathay Fortune Capital Investment.